Standard research protocols typically involve 2-2.5mg twice weekly during loading phases, followed by maintenance dosing
Explicitly claims L-alanyl-L-histidyl-L-lysine:copper(II) as a composition and describes both intradermal injection formulations (100-500 micrograms per 0.1 mL in saline/sterile water) and topical formulations
That pressure, however, does not create evidence
It can work wonders for someone like an athlete or anyone recovering from a wound to their body part, reducing swelling and helping them recover quickly
You are optimizing one system without degrading another
Melanotan II is structurally and pharmacologically distinct from both the more MC1R-skewed -MSH analog approved for erythropoietic protoporphyria and the MC4R-leaning linear cleavage analog approved for a premenopausal hypoactive disorder neither of which is this compound, and neither of which shares the same CAS registry number, molecular formula, or clinical development history